viru
per
se
cellular
activ
ii
studi
underl
mechan
found
tylophorinebas
compound
target
tgev
viral
rna
effect
inhibit
tgev
replic
inhibit
also
lead
antitgev
replic
activ
induc
tgev
infect
found
associ
two
converg
pathway
mediat
phosphoryl
swine
testicular
cell
inhibit
either
jak
famili
inhibitor
silenc
reveal
domin
mediat
phosphoryl
pathway
activ
result
inhibit
overrod
regul
via
final
tylophorinebas
compound
work
cooper
impart
comprehens
antitgev
activ
combin
treatment
wherein
tylophorin
compound
target
tgev
inhibitor
block
altern
domin
activ
mediat
effect
comprehens
either
one
alon
constitut
feasibl
approach
treatment
sarscov
merscov
coronavirus
anim
virus
contain
envelop
positivesens
singlestrand
rna
genom
includ
common
cold
human
coronaviru
cov
sever
acut
respiratori
syndrom
sar
cov
middl
east
respiratori
syndrom
mer
cov
porcin
transmiss
gastroenter
viru
tgev
murin
hepat
viru
mhv
etc
sinc
sar
outbreak
mortal
rate
novel
antisarscov
treatment
vigor
pursu
new
case
sar
report
sinc
outbreak
anoth
novel
coronaviru
merscov
time
mortal
rate
came
light
date
neither
commerci
avail
vaccin
human
coronavirus
specif
treatment
sarscov
merscov
avail
coronavirus
primarili
infect
upper
respiratori
gastrointestin
tract
induc
host
inflamm
nuclear
factor
activ
coronavirus
usual
respons
mediat
product
proinflammatori
cytokin
chemokin
thu
play
import
role
pathogenesi
diseas
caus
coronavirus
inhibit
inflamm
induc
coronaviru
mice
report
increas
surviv
rate
thu
inhibitor
constitut
promis
class
antivir
infect
caus
pathogen
coronavirus
howev
target
limit
intrins
pathway
complex
cross
talk
pathway
drug
resist
addit
mani
small
chemic
molecul
target
either
viral
entri
intracellular
viral
life
cycl
report
impart
anticoronaviru
activ
despit
advanc
howev
sarscov
merscov
remain
untreat
diseas
novel
therapi
sought
publish
xx
xx
xxxx
open
wwwnaturecomscientificreport
scientif
report
tylophorin
base
compound
whether
isol
plant
eg
asclepiadacea
moracea
chemic
synthes
exert
potent
anticoronavir
activ
varieti
coronavirus
includ
sarscov
mhv
tgev
underli
mechan
inhibitori
effect
target
unknown
significantli
activ
infect
coronavirus
eg
tgev
mhv
etc
otherwis
coronavir
nucleocapsid
n
protein
play
vital
role
regul
viral
genom
replic
host
gene
transcript
therefor
combin
treatment
inhibit
coronaviru
per
se
eg
viral
genom
replic
block
cellular
activ
coronavirus
promis
approach
develop
anticoronavir
tgev
infect
swine
testicular
st
cell
constitut
surrog
system
search
studi
potenti
anticoronaviru
agent
herein
report
tylophorinebas
compound
exert
potent
antitgev
replic
directli
target
viral
rnaribonucleoprotein
rnp
complex
viral
replicationsynthesi
inhibit
also
lead
antitgev
replic
combin
treatment
consist
tylophorin
compound
inhibitor
act
addit
synerg
effect
comprehens
inhibit
tgev
replic
either
alon
tylophorinebas
compound
interact
tgev
viral
rnarnp
inhibit
tgev
rna
replic
tylophorin
compound
exert
potent
anticoronaviru
activ
mechan
action
remain
unknown
previous
report
tylophorinebas
compound
exert
anticanc
activ
predominantli
target
rnp
complex
contain
proteincmyc
mrna
carcinoma
cell
accordingli
investig
whether
observ
antitgev
activ
aris
target
viral
rnp
first
demonstr
biotinyl
tylophorin
biotinxss
see
fig
chemic
structur
interact
purifi
tgev
viral
rna
pulldown
experi
use
streptavidin
bead
see
materi
method
fig
interact
biotinyl
tylophorin
tgev
viral
rna
enhanc
addit
recombin
tgev
n
protein
rnadepend
rna
polymeras
rdrp
dose
depend
manner
fig
moreov
cellular
coloc
tgev
viral
nascent
rna
n
protein
fluoresc
tylophorin
compound
surround
nuclei
tgev
infect
cell
also
observ
fig
secondli
rtqpcr
also
demonstr
tylophorin
base
compound
fig
profoundli
inhibit
tgev
viral
replic
diminish
viral
rna
copi
order
magnitud
fig
thirdli
use
uridin
eu
label
newli
synthes
rna
clearli
demonstr
tylophorin
compound
either
tylophorin
dbq
inhibit
nascent
viral
rna
synthesi
thu
block
coloc
viral
nascent
rna
either
n
protein
fig
rdrp
fig
around
nuclei
induct
associ
inflamm
activ
st
cell
upon
tgev
infect
demonstr
western
analysi
phosphoryl
fig
luciferas
report
assay
activ
fig
inhibitor
appli
diminish
phosphoryl
profoundli
inhibit
phosphoryl
fig
decreas
amount
phosphoryl
transloc
nuclei
fig
therebi
conceiv
inhibit
activ
howev
signific
amount
phosphoryl
persist
tgev
infect
st
cell
treatment
fig
therefor
reason
pathway
exist
activ
tgev
infect
st
cell
capabl
mediat
phosphoryl
even
axi
inhibit
search
pathway
pharmacolog
inhibitor
addit
effector
pathway
mediat
phosphoryl
found
jak
pathway
inhibitor
diminish
phosphoryl
tgev
infect
st
cell
fig
b
even
presenc
tylophorin
fig
moreov
diminish
protein
level
phosphoryl
form
fig
tylophorin
howev
tylophorin
moder
increas
level
tgev
infect
st
cell
nuclei
fig
final
abl
significantli
diminish
phosphoryl
presenc
absenc
tylophorin
tgev
infect
cell
demonstr
western
analysi
fig
c
immunofluoresc
assay
ifa
transloc
nuclei
fig
expect
individu
significantli
block
induct
target
gene
tgev
infect
st
cell
fig
differenti
combinatori
effect
tylophorin
inhibitor
tylophorin
work
addit
manner
antagon
tgev
inhibit
sinc
tylophorin
jak
famili
inhibitor
exhibit
differenti
effect
regul
tgev
infect
st
cell
drug
combin
experi
perform
investig
combin
effect
antitgev
replic
use
ifa
assay
describ
materi
method
abl
exert
antitgev
activ
ec
maxim
effect
concentr
combin
index
valu
ed
maxim
effect
dose
tylophorin
calcul
use
calcusyn
softwar
rang
thu
tylophorin
inhibit
tgev
activ
antagonist
manner
fig
contrast
abl
exert
antitgev
activ
ec
tylophorin
work
addit
antitgev
activ
combin
index
valu
ed
fig
lastli
treatment
abl
enhanc
antitgev
activ
tylophorin
dbq
dose
depend
manner
determin
n
protein
express
fig
consist
addit
effect
combin
treatment
tylophorin
antitgev
activ
fig
b
biotinyl
tylophorin
interact
tgev
viral
rna
c
tgev
n
protein
enhanc
associ
biotinyl
tylophorin
tgev
viral
rna
total
rna
extract
tgev
infect
st
cell
hpi
subject
pulldown
experi
biotinyl
tylophorin
biotinxss
h
absenc
presenc
recombin
n
protein
hisrdrp
indic
amount
pull
complex
subject
analysi
rtpcr
tgev
specif
primer
design
region
tgev
n
pro
gene
bodi
ribosom
rna
use
input
control
pulldown
assay
biotinyl
tylophorin
biotinxss
respect
label
bioti
biox
b
chemic
structur
tylophorin
dbq
c
tylophorin
compound
inhibit
tgev
replic
tgev
infect
st
cell
moi
treat
indic
dose
compound
hpi
harvest
subject
total
rna
extract
determin
viral
copi
number
see
materi
method
shown
mean
sd
three
independ
experi
triplic
p
p
versu
compound
treatment
tylophorin
compound
inhibit
tgev
nascent
viral
rna
replic
n
rdrp
protein
express
tgev
infect
compound
treatment
eu
addit
label
nascent
rna
perform
sequenc
upper
scheme
shown
black
arrow
line
green
arrow
line
repres
period
n
rdrp
b
protein
express
sinc
tgev
infect
red
one
nascent
rna
synthesi
sinc
eu
addit
actinomycin
act
ad
hpi
inhibit
dnadepend
rna
polymeras
immunofluoresc
stain
follow
fixat
cell
detect
incorpor
alkynemodifi
eu
azidederivat
alexa
fluorophor
use
click
chemistri
nascent
viral
rna
red
immunostain
fitcmous
igg
antitgev
n
rdrp
b
protein
green
stain
blue
visual
nuclei
fluoresc
imag
acquir
use
leica
tsc
laserscan
confoc
microscop
bar
combin
treatment
tylophorinebas
compound
cooper
result
comprehens
ultim
reduct
tgev
titer
infect
st
cell
tgev
exhibit
log
phase
increas
viral
yield
within
first
h
reach
plateau
hpi
titer
pfu
plagu
form
unit
ml
fig
treatment
tylophorin
dbq
significantli
block
viral
replic
diminish
viral
yield
tgev
infect
st
cell
dose
depend
manner
fig
treatment
either
tylophorin
dbq
complet
block
viral
replic
reduc
viral
titer
concentr
nm
nm
respect
result
reduct
viral
yield
order
magnitud
decreas
viral
yield
pfuml
order
magnitud
concentr
though
limit
poor
solubl
moder
cytotox
fig
achiev
order
magnitud
decreas
viral
yield
pfuml
concentr
arm
inhibit
either
target
tgev
viral
complex
cellular
activ
abl
profoundli
reduc
viral
replic
st
cell
treat
combin
either
tylophorin
nm
nm
dbq
nm
nm
viral
titer
reduc
antagonist
manner
say
reduct
titer
achiev
combin
treatment
less
sum
viral
titer
reduct
achiev
tylophorin
dbq
separ
fig
result
consist
aforement
antagonist
effect
fig
hand
st
cell
treat
combin
either
tylophorin
dbq
opposit
effect
addit
synergist
effect
observ
fig
exampl
lower
ic
valu
antitgev
activ
combin
tylophorin
nm
nm
nm
dbq
nm
nm
nm
combin
treatment
exert
addit
manner
synergist
effect
reduct
tgev
viral
titer
maximum
synerg
effect
one
order
magnitud
fig
thu
reduct
viral
yield
cooper
enhanc
combin
tylophorin
dbq
fig
result
consist
aforement
addit
effect
fig
tylophorin
base
compound
moreov
posttreat
result
enhanc
reduct
viral
titer
pretreat
fig
tylophorin
block
de
novo
protein
synthesi
arrest
rnp
contain
protein
mrna
mechan
account
tylophorin
antagon
antitgev
activ
elucid
protein
express
elimin
tylophorin
fig
first
examin
whether
tylophorin
downregul
transcript
thu
inhibit
protein
express
rtpcr
detect
amount
mrna
tgev
infect
cell
treat
tylophorin
mrna
significantli
induc
upon
tgev
infect
st
cell
howev
tylophorin
decreas
tgev
induc
mrna
level
manifest
hpi
fig
thu
tylophorin
diminish
protein
level
transcript
downregul
secondli
examin
whether
proteasom
degrad
involv
tylophorin
disabl
induct
phosphoryl
form
hpi
tgev
proteasom
inhibitor
abl
significantli
increas
level
phosphoryl
upon
tgev
infect
howev
coadminist
tylophorin
abl
recov
protein
level
elimin
tylophorin
wherea
level
phosphoryl
form
recov
level
induc
tgev
attribut
fact
phosphoryl
form
subject
proteasom
degrad
function
block
process
fig
thu
tylophorin
undergo
block
proteasom
degrad
reduc
protein
level
thirdli
examin
whether
tylophorin
block
de
novo
protein
synthesi
protein
use
clickit
hpg
tamra
labellingdetect
method
trace
newli
synthes
protein
shown
fig
amount
newli
synthes
significantli
increas
time
tgev
infect
treatment
tylophorin
complet
elimin
de
novo
synthesi
fig
sinc
tylophorin
report
block
cmyc
protein
express
arrest
rnp
complex
contain
protein
cmyc
mrna
cmyc
highli
express
carcinoma
cell
examin
whether
tylophorin
also
block
protein
express
induc
upon
tgev
infect
fig
similar
mechan
biotinyl
tylophorin
compound
appli
pulldown
experi
cell
lysat
subsequ
western
analys
rna
extract
rtqpcr
use
identifi
interact
molecul
eg
mrna
mrna
pull
biotinyl
tylophorin
biotinxss
tgev
infect
st
cell
mrna
also
pull
mock
transfect
cell
fig
protein
pull
signific
amount
biotinyl
tylophorin
biotinxss
lysat
mock
tgev
infect
st
cell
within
first
hpi
protein
compon
associ
rnp
complex
fig
furthermor
mrna
rrna
coimmunoprecipit
presenc
biotinyl
tylophorin
tgev
infect
st
cell
fig
therefor
suggest
tylophorin
interact
arrest
rnp
complex
protein
mrna
therebi
block
protein
express
induc
tgev
infect
tylophorin
reduc
protein
level
consequ
sequest
liber
subject
phosphoryl
activ
tgev
infect
st
cell
inhibit
therebi
inhibit
phosphoryl
activ
howev
associ
pathway
mediat
altern
domin
phosphoryl
also
led
activ
therefor
tylophorin
antagon
mediat
antitgev
activ
liber
via
diminish
protein
express
ident
specif
member
jak
famili
respons
inhibit
phosphoryl
sought
becam
phosphoryl
infect
st
cell
tgev
moreov
increas
phosphoryl
event
except
decreas
tylophorin
treatment
fig
left
panel
furthermor
phosphoryl
event
presenc
absenc
tylophorin
inhibit
dose
depend
manner
fig
right
panel
effect
knockdown
phosphoryl
tgev
infect
st
cell
also
studi
control
shrna
transduc
st
cell
vector
control
knockdown
express
result
st
cell
st
cell
harbor
control
shrna
infect
tgev
respect
presenc
absenc
tylophorin
fig
result
show
phosphoryl
dramat
diminish
st
cell
presenc
tylophorin
treatment
phosphoryl
significantli
decreas
knockdown
cell
compar
control
shrna
accordingli
conclud
mediat
altern
domin
phosphoryl
tgev
infect
st
cell
inhibit
knockdown
gene
silenc
abl
profoundli
block
phosphoryl
without
tylophorin
treatment
sinc
tylophorin
arrest
mrna
reduc
protein
express
liber
fig
c
diminish
phosphoryl
via
inhibit
fig
reason
capabl
work
addit
manner
tylophorin
antitgev
activ
fig
thu
addit
high
potenc
anticoronavir
tylophorin
simultan
block
viral
induc
host
cell
could
diminish
occurr
inflammatori
respons
eg
fig
therefor
constitut
effect
comprehens
cooper
anticoronavir
strategi
fig
human
coronavirus
constitut
grave
threat
public
health
situat
exemplifi
outbreak
sarscov
merscov
date
howev
still
specif
antivir
treatment
vaccin
avail
human
cov
infect
current
standard
care
affect
individu
focus
symptom
relief
sever
case
support
vital
organ
function
cytokin
storm
inflamm
factor
person
infect
sar
mer
usual
result
activ
accordingli
target
effect
symptom
relief
help
host
combat
cov
replic
sensibl
approach
especi
combin
antivir
compound
tylophorin
compound
exert
potent
oral
activ
broad
spectrum
anticoronavir
activ
ec
valu
low
nm
rang
sarscov
mhv
tgev
herein
tgev
use
surrog
system
coronaviru
dissect
underli
mechan
action
anticoronavir
tylophorin
compound
tgev
infect
st
cell
tylophorin
compound
target
n
protein
associ
viral
replic
complex
fig
block
mediat
activ
fig
respect
found
combin
tylophorin
good
strategi
elimin
tgev
st
cell
combin
strategi
open
promis
futur
avenu
research
treatment
sarscov
merscov
interact
biotinyl
tylophorin
tgev
viral
rna
enhanc
addit
recombin
tgev
n
protein
fig
recombin
tgev
n
protein
exert
effect
interact
biotinyl
tylophorin
mrna
fig
therefor
futur
develop
tylophorin
deriv
retain
bind
charact
tgev
viral
rnp
complex
mrna
rnp
complex
thought
worthwhil
select
tylophorin
deriv
provid
option
combin
treatment
inhibitor
moreov
tgev
n
protein
report
bind
viral
genom
subgenom
tr
facilit
viral
transcript
replic
degre
rna
occup
chaperon
protein
eg
n
protein
delic
regul
biolog
properti
function
rna
structur
switch
nucleoprotein
complex
crowd
state
overcrowd
one
eg
overload
n
protein
result
loss
rna
function
eg
freez
viral
transcriptionrepl
tylophorin
bind
may
increas
n
protein
load
also
prevent
releas
n
protein
replic
rnp
complex
therefor
suggest
tylophorin
multipl
signal
pathway
network
might
cooper
orchestr
activ
biolog
system
antivir
agent
may
differenti
pharmacolog
effect
activ
therefor
combin
treatment
antivir
agent
inhibitor
avoid
antagonist
effect
interestingli
tgev
infect
st
cell
significantli
inhibit
phosphoryl
fig
indic
exist
pathway
altern
mediat
phosphoryl
independ
mediat
pathway
obvious
least
two
key
pathway
associ
activ
tgev
infect
st
cell
one
phosphoryl
mediat
phosphoryl
fig
regard
charact
tylophorin
arrest
mrna
block
protein
express
fig
reason
inhibit
pathway
synerg
tylophorin
exert
antitgev
activ
st
cell
nonetheless
block
mediat
activ
pathway
effici
diminish
phosphoryl
nuclear
transloc
treatment
tylophorin
cotreat
tgev
infect
st
cell
fig
knockdown
gene
silenc
bolster
domin
role
activ
tgev
infect
st
cell
phosphoryl
dramat
decreas
tgev
infect
defici
cell
compar
shrna
control
cell
without
tylophorin
treatment
fig
collect
tylophorin
antagon
inhibit
axi
work
addit
manner
inhibit
jak
pathway
mediat
phosphoryl
tgev
inhibit
jak
inhibitor
confer
inhibit
tgev
infect
cell
also
potenti
work
tylophorin
compound
block
mediat
phosphoryl
applic
fig
interact
host
pathogen
antivir
agent
complic
antivir
effect
singl
agent
easili
compromis
thu
optim
combin
therapi
constitut
effect
anticoronavir
addit
high
potenc
anticoronavir
tylophorin
simultan
block
viral
induc
inflammatori
respons
host
cell
could
diminish
occurr
cytokin
storm
eg
thu
combin
treatment
via
target
n
protein
associ
coronavir
rna
synthesi
tylophorin
compound
block
mediat
activ
offer
effect
ultim
cooper
anticoronavir
strategi
fig
conclus
tylophorin
compound
directli
target
viral
rna
complex
complet
block
viral
replic
reduc
viral
titer
also
found
inhibit
inhibit
activ
phosphoryl
subsequ
cytokin
product
eg
also
work
cooper
tylophorin
deliv
comprehens
ultim
antitgev
activ
strain
tgev
grown
propag
describ
ifa
perform
describ
briefli
st
cell
cellswel
cellswel
plate
without
h
pretreat
either
tylophorin
indic
inhibitor
infect
tgev
multipl
infect
moi
ifa
perform
h
postinfect
hpi
antibodi
spike
n
protein
tgev
cell
treat
differ
concentr
test
compound
result
assay
use
obtain
doserespons
curv
ec
valu
determin
end
point
dilut
assay
determin
viru
titer
perform
describ
briefli
supernat
obtain
cultur
tgev
infect
st
cell
moi
indic
treatment
subject
viral
titer
determin
via
end
point
dilut
assay
reed
muench
method
use
determin
tissu
cultur
infect
dose
chemic
reagent
dimethylsulfoxid
dmso
use
vehicl
control
drug
treatment
chemic
reagent
purchas
follow
sourc
highperform
liquid
chromatographygrad
dmso
sigmaaldrich
biotinylatedtylophorin
pulldown
assay
purifi
total
rna
cell
lysat
tgev
infect
st
cell
moi
harvest
indic
hpi
incub
biotinxss
biotinyl
tylophorin
rna
lysat
respect
h
associ
complex
pull
use
streptavidin
dynabead
invitrogen
h
subject
western
analysi
rna
isol
rtpcr
western
blot
use
identifi
protein
compon
pulldown
biotinyl
tylophorinebound
rna
elut
aforement
pulldown
trizol
reagent
invitrogen
rtpcr
use
analyz
associ
compon
plasmid
encod
gstn
fusion
protein
construct
insert
tgev
n
code
region
gstexpress
vector
ge
healthcar
escherichia
coli
harbor
cultur
overnight
overnight
bacteri
cultur
dilut
cultur
medium
mm
iptg
ad
induc
gstn
protein
express
h
result
bacteri
pellet
subject
gstn
protein
purif
use
glutathionesepharos
bead
sigmaaldrich
per
manufactur
recommend
n
protein
obtain
gstn
digest
presciss
proteas
follow
manufactur
instruct
ge
healthcar
buckinghamshir
uk
anoth
plasmid
encod
hisrdrp
fusion
protein
rdrp
construct
insert
tgev
rdrp
code
region
hisexpress
vector
novagen
escherichia
coli
rosetta
tm
plyss
harbor
rdrp
cultur
overnight
overnight
bacteri
cultur
dilut
cultur
medium
mm
iptg
ad
induc
hisrdrp
protein
express
h
result
bacteri
pellet
subject
hisrdrp
protein
purif
use
ni
sepharos
fast
flow
resin
ge
healthcar
per
manufactur
recommend
purifi
protein
tgev
n
hisrdrp
analyz
sdspage
quantifi
bca
protein
assay
biorad
confoc
microscopi
immunofluoresc
stain
immunofluoresc
stain
perform
previous
describ
immunofluoresc
stain
antibodi
cell
signal
fluorescein
isothiocyan
fitc
conjug
antimous
immunoglobulin
capel
inc
use
immunofluoresc
stain
tgev
n
rdrp
protein
eu
incorpor
de
novo
rna
perform
follow
clickit
rna
alexa
fluor
imag
kit
invitrogen
appli
label
eu
detect
nascent
viral
rna
tgev
infect
st
cell
per
manufactur
recommend
gener
st
cell
grown
coverslip
cellswel
plate
infect
tgev
moi
subsequ
treat
actinomycin
inhibit
dna
depend
rna
polymeras
hpi
tylophorin
dbq
hpi
eu
mm
ad
hpi
incub
anoth
hour
allow
incorpor
eu
newli
synthes
rna
result
cell
fix
use
paraformaldehyd
permeabil
use
triton
hpi
subsequ
fix
cell
incub
alexa
solut
min
rt
dark
ligat
eu
coupl
alexa
red
fluoresc
moieti
later
detect
wash
three
time
pb
subsequ
cell
incub
primari
monoclon
antibodi
tgev
n
rdrp
protein
three
five
wash
cell
ad
solut
fitcconjug
antimous
immunoglobulin
capel
inc
n
rdrp
protein
incub
anoth
h
rt
subsequ
nuclei
stain
dapi
min
rt
three
five
wash
result
coverslip
mount
use
vectashield
mount
medium
vector
laboratori
burlingam
ca
fluoresc
imag
acquir
use
leica
tsc
laserscan
confoc
microscop
describ
previous
western
blot
analysi
western
blot
perform
describ
cell
lysat
pull
complex
subject
sdspolyacrylamid
gel
electrophoresi
western
blot
analys
antibodi
millipor
merck
chemicon
pittsburgh
pa
santa
cruz
glyceraldehyd
dehydrogenas
gapdh
cell
signal
technolog
proteintech
group
horseradish
peroxidaseconjug
secondari
antibodi
perkinelm
enhanc
chemiluminesc
detect
reagent
western
blot
chemiluminesc
reagent
plu
perkinelm
use
accord
manufactur
instruct
detect
antigenantibodi
complex
transfect
luciferas
assay
st
cell
seed
densiti
cellswel
plate
grown
cultur
medium
six
hour
later
cell
transfect
report
plasmid
ngwell
use
accord
manufactur
recommend
incub
h
cell
infect
tgev
moi
mock
infect
cell
harvest
hpi
luciferas
assay
subsequ
medium
remov
glo
lysi
buffer
promega
ad
per
well
result
lysat
subject
luciferas
activ
analysi
luciferas
activ
normal
protein
concentr
cell
lysat
rna
isol
rtqpcr
experi
perform
describ
mock
tgev
infect
moi
lysat
process
prepar
indic
time
point
without
compound
treatment
total
rna
extract
trizol
reagent
invitrogen
rel
mrna
express
level
determin
semirtqpcr
analyz
gelpro
analyz
program
media
cybernet
normal
housekeep
gene
need
rna
complex
pulldown
experi
either
biotinyl
tylophorinebiotinxss
immunoprecipit
anticaprin
antibodi
subject
trizol
extract
prior
rtqpcr
analys
quantifi
viral
copi
number
indic
rtqpcr
analys
known
amount
number
plasmid
see
materi
method
use
set
standard
curv
calcul
viral
copi
number
treatment
primer
pair
use
rtqpcr
n
protein
pro
ribosom
rna
treatment
hpi
harvest
dilut
proper
concentr
determin
amount
secret
use
enzymelink
immunosorb
assay
kit
porcin
r
system
inc
per
manufactur
recommend
tamra
label
detect
de
novo
synthes
protein
assay
perform
describ
briefli
st
cell
wash
pb
cultur
methioninefre
dmem
gibcolif
technolog
h
prior
addit
tylophorin
clickit
hpg
lhomopropargylglycin
reactiv
methionin
analog
invitrogen
anoth
h
follow
infect
tgev
moi
h
cell
harvest
subject
click
reaction
tamra
tetramethylrhodamin
invitrogen
label
de
novo
synthes
protein
clickit
protein
reaction
buffer
accord
manufactur
protocol
invitrogen
result
cell
lysat
immunoprecipit
cell
signal
technolog
overnight
constant
agit
prior
incub
protein
g
agaros
millipor
anoth
h
three
five
wash
specif
immunoprecipit
protein
elut
analyz
western
immunoblot
analysi
antibodi
tamra
thermo
fisher
scientif
gene
silenc
st
cell
seed
cultur
plate
confluenc
day
prior
transduct
pseudotyp
lentiviru
contain
human
shrna
clone
id
neg
control
shrna
shlacz
clone
id
taiwan
nation
rnai
core
facil
academia
sinica
taiwan
h
post
transduct
cell
cultur
presenc
puromycin
select
statist
analysi
statist
signific
two
group
evalu
unpair
student
test
use
denot
statist
signific
p
p
p
respect
